Spironolactone Tablet, Coated
Product Images NDC 70518-3625

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 70518-3625). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
A Kaplan-Meier survival curve chart showing probability over time in months for two groups: Spironolactone (n=822) and Placebo (n=841). The chart illustrates a statistically significant difference with a log-rank p-value less than 0.001, indicating differing survival probabilities between the groups over approximately 36 months.*
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
A forest plot diagram illustrating hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups related to Spironolactone treatment compared to placebo. Subgroups include age, sex, race, LVEF percentage, heart failure type, NYHA classification, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The plot shows the comparative effectiveness with direction indicated from Spironolactone better to placebo better.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Spironolactone 25 mg coated tablets packaging label from RemedyRepack Inc. The label shows a quantity of 30 tablets and lists the manufacturer as Oxford Pharmaceuticals, LLC. The label includes barcode, QR code, NDC 70518-3625-00, and storage instructions, advising to keep medication out of the reach of children.*
FDA Label Image

20 (Spironolactone Tablets Usp 1)

20 (Spironolactone Tablets Usp 1)
Chemical structure diagram of spironolactone, illustrating the molecular arrangement and bonds of the active ingredient spironolactone in the product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.